IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients. Giacomini E, Severa M, Rizzo F, Mechelli R, Annibali V, Ristori G, Riccieri V, Salvetti M, Coccia E M Eur J Immunol. 2013 May 2. PMID: 23636665. Abstract CommentRecommendBookmarkWatch